↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
6 news outlets
policy
2 policy sources
twitter
58 X users
patent
16 patents
guideline
4 clinical guideline sources
podcasts
2 podcasts

Readers on

mendeley
396 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Published in
Lancet Oncology, December 2021
DOI 10.1016/s1470-2045(21)00591-x
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 58 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 396 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 396 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 44 11%
Student > Ph. D. Student 34 9%
Other 27 7%
Student > Bachelor 20 5%
Student > Doctoral Student 15 4%
Other 51 13%
Unknown 205 52%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 102 26%
Biochemistry, Genetics and Molecular Biology 27 7%
Pharmacology, Toxicology and Pharmaceutical Science 12 3%
Agricultural and Biological Sciences 8 2%
Immunology and Microbiology 8 2%
Other 31 8%
Unknown 208 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 111. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2026.
All research outputs
#483,617
of 34,517,649 outputs
Outputs from Lancet Oncology
#639
of 8,014 outputs
Outputs of similar age
#10,063
of 564,434 outputs
Outputs of similar age from Lancet Oncology
#19
of 111 outputs
Altmetric has tracked 34,517,649 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,014 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 564,434 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.